Cytochrome P450 Enzymes: |
---|
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0008152; metabolic process | GO:0016098; monoterpenoid metabolic process | 1.895E-08 | 4.126E-05 | CYP2C19, CYP2C9, CYP2D6 |
BP | GO:0009987; cellular process | GO:0032849; positive regulation of cellular pH reduction | 3.054E-06 | 4.750E-03 | CA2, CA7 |
BP | GO:0051179; localization | GO:0015701; bicarbonate transport | 4.560E-17 | 4.965E-13 | CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9 |
BP | GO:0008152; metabolic process | GO:0006730; one-carbon metabolic process | 3.199E-15 | 1.742E-11 | CA1, CA12, CA2, CA4, CA6, CA7, CA9 |
MF | GO:0005488; binding | GO:0008270; zinc ion binding | 7.638E-07 | 1.288E-03 | CA1, CA12, CA2, CA4, CA6, CA7, CA9, TP53 |
MF | GO:0003824; catalytic activity | GO:0008395; steroid hydroxylase activity | 5.565E-06 | 7.128E-03 | CYP2C19, CYP2C9, CYP2D6 |
MF | GO:0003824; catalytic activity | GO:0004089; carbonate dehydratase activity | 1.682E-21 | 3.664E-17 | CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9 |
Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|
hsa00232 | Caffeine metabolism_Homo sapiens_hsa00232 | 4.991E-03 | 2.606E-02 | XDH |
hsa00590 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.733E-03 | 1.870E-02 | CYP2C9; CYP2C19 |
hsa00591 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 3.795E-04 | 5.946E-03 | CYP2C9; CYP2C19 |
hsa00910 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.807E-21 | 4.518E-19 | CA12; CA1; CA2; CA4; CA7; CA6; CA9; CA14 |
hsa00980 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.393E-03 | 1.874E-02 | CYP2C9; CYP2D6 |
hsa00982 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 4.296E-05 | 2.019E-03 | CYP2C9; CYP2D6; CYP2C19 |
hsa01100 | Metabolic pathways_Homo sapiens_hsa01100 | 1.019E-03 | 1.368E-02 | CYP2C9; GAA; ALPL; CYP2C19; HSD17B10; XDH |
hsa04010 | MAPK signaling pathway_Homo sapiens_hsa04010 | 1.989E-03 | 1.870E-02 | MAPT; TP53; NFKB1 |
hsa04066 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 4.698E-03 | 2.597E-02 | PFKFB3; NFKB1 |
hsa04071 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 6.321E-03 | 2.971E-02 | TP53; NFKB1 |
ICD10 Disease Category | Disease Name | ICD10 Code | Linked Targets |
---|---|---|---|
A00-B99: Certain infectious and parasitic diseases | Malaria | B54 | CYP2D6 |
A00-B99: Certain infectious and parasitic diseases | Bacterial infections | A00-B99 | CYP2C9 |
A00-B99: Certain infectious and parasitic diseases | Fungal infections | B35-B49 | RAB9A |
A00-B99: Certain infectious and parasitic diseases | Anthelmintic | B89 | ALPL |
C00-D49: Neoplasms | Cancer | C00-C96 | CA9; CA1; NFKB1; TP53 |
C00-D49: Neoplasms | Late-stage solid tumors | C00-C75, C7A, C7B, D10-D36, D3A | TP53 |
C00-D49: Neoplasms | Lymphoma | C81-C86 | CA9 |
C00-D49: Neoplasms | Renal cancer | C64 | CA9 |
C00-D49: Neoplasms | Oral cavity cancer | C00-C08 | TP53 |
C00-D49: Neoplasms | Solid tumours | C00-D48 | PFKFB3; CA9; TP53 |